Corey Cox

ORCID: 0000-0001-9042-5982
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Hypoxia, and Metabolism
  • Asthma and respiratory diseases
  • Adipose Tissue and Metabolism
  • Machine Learning in Bioinformatics
  • Chromosomal and Genetic Variations
  • Cancer-related Molecular Pathways
  • Genomics and Phylogenetic Studies
  • Histone Deacetylase Inhibitors Research
  • RNA and protein synthesis mechanisms
  • Epigenetics and DNA Methylation
  • Microtubule and mitosis dynamics
  • Ubiquitin and proteasome pathways
  • Immune responses and vaccinations
  • Gut microbiota and health
  • Wound Healing and Treatments
  • Genomics and Rare Diseases
  • Inhalation and Respiratory Drug Delivery
  • Immune Response and Inflammation
  • IL-33, ST2, and ILC Pathways
  • Tendon Structure and Treatment
  • Allergic Rhinitis and Sensitization
  • Plant Disease Resistance and Genetics
  • 14-3-3 protein interactions
  • Cytokine Signaling Pathways and Interactions
  • Bioinformatics and Genomic Networks

University of Colorado Anschutz Medical Campus
2021-2024

University of Colorado Denver
2014-2024

University of California, Santa Barbara
2007-2010

Since the onset of SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR1. Host epigenome manipulation post coronavirus infection2-4 suggests that DNA methylation signatures may differentiate patients with infection from uninfected individuals, and help predict COVID-19 disease severity, even at initial presentation.We customized Illumina's Infinium MethylationEPIC array to enhance immune response detection profiled peripheral blood samples 164 longitudinal measurements severity...

10.1038/s43856-021-00042-y article EN cc-by Communications Medicine 2021-10-26

Bridging the gap between genetic variations, environmental determinants, and phenotypic outcomes is critical for supporting clinical diagnosis understanding mechanisms of diseases. It requires integrating open data at a global scale. The Monarch Initiative advances these goals by developing ontologies, semantic models, knowledge graphs translational research. App an integrated platform combining about genes, phenotypes, diseases across species. Monarch's APIs enable access to carefully...

10.1093/nar/gkad1082 article EN cc-by Nucleic Acids Research 2023-11-24

Asthma has striking disparities across ancestral groups, but the molecular underpinning of these differences is poorly understood and minimally studied. A goal Consortium on among African-ancestry Populations in Americas (CAAPA) to understand multi-omic signatures asthma focusing populations African ancestry. RNASeq DNA methylation data are generated from nasal epithelium including cases (current asthma, N = 253) controls (never-asthma, 283) 7 different geographic sites identify...

10.1038/s41467-024-48507-7 article EN cc-by Nature Communications 2024-05-28

Carbendazim (methyl 2-benzimidazolecarbamate) is widely used as a systemic fungicide in human food production and appears to act on fungal tubulin. However, it also inhibits proliferation of cancer cells, including drug- multidrug-resistant p53-deficient cell lines. Because its promising preclinical anti-tumor activity, has undergone phase I clinical trials under further development. Although weakly polymerization brain microtubules induces G<sub>2</sub>/M arrest tumor mechanism action cells...

10.1124/jpet.108.143537 article EN Journal of Pharmacology and Experimental Therapeutics 2008-11-10

Abstract Background Previously, 3% of the human genome has been annotated as simple sequence repeats (SSRs), similar to proportion protein coding. The origin much is not well annotated, however, and some unidentified regions are likely be ancient SSR-derived identified by current methods. identification these complicated because SSRs appear evolve through complex cycles expansion contraction, often interrupted mutations that alter both repeated motif mutation rate. We applied an empirical,...

10.1186/s13100-020-00206-y article EN cc-by Mobile DNA 2020-02-17
Anna V. Mikhaylova Caitlin McHugh Linda M. Polfus Laura M. Raffield Meher Preethi Boorgula and 88 more Thomas W. Blackwell Jennifer A. Brody Jai Broome Nathalie Chami Ming‐Huei Chen Matthew P. Conomos Corey Cox Joanne E. Curran Michelle Daya Lynette Ekunwe David C. Glahn Nancy L. Heard‐Costa Heather M. Highland Brian D. Hobbs Yann Ilboudo Deepti Jain Leslie A. Lange Tyne W. Miller‐Fleming Yuan‐I Min Jee‐Young Moon Michael Preuß Jonathon Rosen Kathleen A. Ryan Albert V. Smith Quan Sun Praveen Surendran Paul S. de Vries Klaudia Walter Zhe Wang Marsha M. Wheeler Lisa R. Yanek Xue Zhong Gonçalo R. Abecasis Laura Almasy Kathleen C. Barnes Terri H. Beaty Lewis C. Becker John Blangero Eric Boerwinkle Adam S. Butterworth Sameer Chavan Michael H. Cho Hélène Choquet Adolfo Correa Nancy J. Cox Dawn L. DeMeo Nauder Faraday Myriam Fornage Robert E. Gerszten Lifang Hou Andrew D. Johnson Eric Jorgenson Robert C. Kaplan Charles Kooperberg Kousik Kundu Cecelia Laurie Guillaume Lettre Joshua P. Lewis Bingshan Li Yun Li Donald M. Lloyd‐Jones Ruth J. F. Loos Ani Manichaikul Deborah A. Meyers Braxton D. Mitchell Alanna C. Morrison Debby Ngo Deborah A. Nickerson Suraj S. Nongmaithem Kari E. North Jeffrey R. O’Connell Victor E. Ortega Nathan Pankratz James A. Perry Bruce M. Psaty Stephen S. Rich Nicole Soranzo Jerome I. Rotter Edwin K. Silverman Nicholas L. Smith Hua Tang Russell P. Tracy Timothy A. Thornton Ramachandran S. Vasan Joe Zein Rasika A. Mathias Alexander P. Reiner Paul L. Auer

10.1016/j.ajhg.2021.08.007 article EN publisher-specific-oa The American Journal of Human Genetics 2021-09-27

Abstract Secondary resistance to hormonal therapy for breast cancer commonly develops after an initial response tamoxifen or aromatase inhibitors. Agents abrogate these adaptive changes would substantially enhance the long-term benefits of therapy. Our studies with a stilbene derivative called TMS (2,3′,4,5′-tetramethoxystilbene) identified unexpected effects potential utility treatment tumors secondarily resistant was originally developed as inhibitor cytochrome P450 1B1 block conversion...

10.1158/0008-5472.can-07-0056 article EN Cancer Research 2007-06-15

NAP (Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln) is a neuroprotective peptide that shows cognitive protection in patients with amnestic mild impairment, precursor to Alzheimer's disease. exhibits potent properties several vivo and cellular models of neural injury. While has been found many studies affect microtubule assembly and/or stability neuronal glial cells at fM concentrations, it remained unclear whether acts directly or indirectly on tubulin microtubules. We analyzed the effects (1 fM-1 microM)...

10.3233/jad-2010-1335 article EN Journal of Alzheimer s Disease 2010-03-11

10.1016/s2352-4642(21)00268-6 article EN publisher-specific-oa The Lancet Child & Adolescent Health 2021-11-09

Most common methods for inferring transposable element (TE) evolutionary relationships are based on dividing TEs into subfamilies using shared diagnostic nucleotides. Although originally justified the "master gene" model of TE evolution, computational and experimental work indicates that many generated by these contain multiple source elements. This implies subfamily-based give an incomplete picture relationships. Studies selection, functional exaptation, predictions horizontal transfer may...

10.1371/journal.pgen.1004482 article EN cc-by PLoS Genetics 2014-08-14

Abstract Since the onset of SARS-CoV-2 pandemic, most clinical testing has focused on RT-PCR. Host epigenome manipulation post coronavirus infection suggests that DNA methylation signatures may differentiate patients with from uninfected individuals, and help predict COVID-19 disease severity, even at initial presentation. We customized Illumina’s Infinium Methylation EPIC array to enhance immune response detection profiled peripheral blood samples 164 longitudinal measurements severity 296...

10.21203/rs.3.rs-334297/v1 preprint EN cc-by Research Square (Research Square) 2021-03-22

&lt;div&gt;Abstract&lt;p&gt;Secondary resistance to hormonal therapy for breast cancer commonly develops after an initial response tamoxifen or aromatase inhibitors. Agents abrogate these adaptive changes would substantially enhance the long-term benefits of therapy. Our studies with a stilbene derivative called TMS (2,3′,4,5′-tetramethoxystilbene) identified unexpected effects potential utility treatment tumors secondarily resistant was originally developed as inhibitor cytochrome P450 1B1...

10.1158/0008-5472.c.6495797 preprint EN 2023-03-30
Coming Soon ...